ID   RAVR1_HUMAN             Reviewed;         606 AA.
AC   Q8IY67; A6NMU4; Q8IY60; Q8TF24;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 165.
DE   RecName: Full=Ribonucleoprotein PTB-binding 1;
DE   AltName: Full=Protein raver-1;
GN   Name=RAVER1; Synonyms=KIAA1978;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=11853319; DOI=10.1093/dnares/8.6.319;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXII. The
RT   complete sequences of 50 new cDNA clones which code for large proteins.";
RL   DNA Res. 8:319-327(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 182-606 (ISOFORM 2).
RC   TISSUE=Cervix, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-463, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-463, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-567 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-488 AND SER-567 (ISOFORM 2),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-14, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-463, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-14; THR-463 AND SER-474, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT THR-488 AND SER-567 (ISOFORM 2), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-14 AND THR-463, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-567 (ISOFORM 2), CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-14 AND THR-463, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-463, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Cooperates with PTBP1 to modulate regulated alternative
CC       splicing events. Promotes exon skipping. Cooperates with PTBP1 to
CC       modulate switching between mutually exclusive exons during maturation
CC       of the TPM1 pre-mRNA (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PTBP1, RAVER2, VCL and ACTN1. Part of a complex
CC       containing RAVER1, VCL and ACTN1 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8IY67; O75791: GRAP2; NbExp=3; IntAct=EBI-2105155, EBI-740418;
CC       Q8IY67-1; P18206-2: VCL; NbExp=3; IntAct=EBI-15788272, EBI-11027067;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.
CC       Note=Nuclear, in perinucleolar structures. Shuttles between nucleus and
CC       cytoplasm. Cytoplasm, at focal contacts and cell-cell contacts.
CC       Associated with myotubes during muscle differentiation (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IY67-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IY67-2; Sequence=VSP_017035, VSP_017036;
CC       Name=3;
CC         IsoId=Q8IY67-3; Sequence=VSP_040968, VSP_040969;
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37565.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAB85564.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB075858; BAB85564.1; ALT_SEQ; mRNA.
DR   EMBL; AC011511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC037428; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC037565; AAH37565.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS45960.1; -. [Q8IY67-2]
DR   RefSeq; NP_597709.2; NM_133452.2.
DR   PDB; 3H2U; X-ray; 2.75 A; B/D=39-321.
DR   PDB; 3H2V; X-ray; 2.90 A; E/F/G/H=59-130.
DR   PDB; 3SMZ; X-ray; 1.99 A; A=39-320.
DR   PDB; 3VF0; X-ray; 2.54 A; B=39-321.
DR   PDBsum; 3H2U; -.
DR   PDBsum; 3H2V; -.
DR   PDBsum; 3SMZ; -.
DR   PDBsum; 3VF0; -.
DR   SMR; Q8IY67; -.
DR   BioGRID; 125936; 114.
DR   DIP; DIP-46973N; -.
DR   IntAct; Q8IY67; 10.
DR   MINT; Q8IY67; -.
DR   STRING; 9606.ENSP00000293677; -.
DR   iPTMnet; Q8IY67; -.
DR   PhosphoSitePlus; Q8IY67; -.
DR   BioMuta; RAVER1; -.
DR   DMDM; 74759693; -.
DR   CPTAC; CPTAC-997; -.
DR   EPD; Q8IY67; -.
DR   jPOST; Q8IY67; -.
DR   MassIVE; Q8IY67; -.
DR   MaxQB; Q8IY67; -.
DR   PaxDb; Q8IY67; -.
DR   PeptideAtlas; Q8IY67; -.
DR   PRIDE; Q8IY67; -.
DR   ProteomicsDB; 71118; -. [Q8IY67-1]
DR   ProteomicsDB; 71119; -. [Q8IY67-2]
DR   ProteomicsDB; 71120; -. [Q8IY67-3]
DR   Antibodypedia; 6733; 111 antibodies.
DR   Ensembl; ENST00000615032; ENSP00000479520; ENSG00000161847. [Q8IY67-1]
DR   GeneID; 125950; -.
DR   KEGG; hsa:125950; -.
DR   UCSC; uc060tgw.1; human. [Q8IY67-1]
DR   CTD; 125950; -.
DR   DisGeNET; 125950; -.
DR   GeneCards; RAVER1; -.
DR   HGNC; HGNC:30296; RAVER1.
DR   HPA; ENSG00000161847; Low tissue specificity.
DR   MIM; 609950; gene.
DR   neXtProt; NX_Q8IY67; -.
DR   OpenTargets; ENSG00000161847; -.
DR   PharmGKB; PA144596390; -.
DR   VEuPathDB; HostDB:ENSG00000161847.13; -.
DR   eggNOG; KOG0148; Eukaryota.
DR   GeneTree; ENSGT00940000160550; -.
DR   InParanoid; Q8IY67; -.
DR   OMA; GPSRHRM; -.
DR   OrthoDB; 249777at2759; -.
DR   PhylomeDB; Q8IY67; -.
DR   PathwayCommons; Q8IY67; -.
DR   BioGRID-ORCS; 125950; 16 hits in 990 CRISPR screens.
DR   ChiTaRS; RAVER1; human.
DR   EvolutionaryTrace; Q8IY67; -.
DR   GeneWiki; RAVER1; -.
DR   GenomeRNAi; 125950; -.
DR   Pharos; Q8IY67; Tbio.
DR   PRO; PR:Q8IY67; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8IY67; protein.
DR   Bgee; ENSG00000161847; Expressed in muscle tissue and 115 other tissues.
DR   ExpressionAtlas; Q8IY67; baseline and differential.
DR   Genevisible; Q8IY67; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   CDD; cd12663; RRM1_RAVER1; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034635; RAVER1.
DR   InterPro; IPR034633; RAVER1_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR23189:SF46; PTHR23189:SF46; 2.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; RNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   CHAIN           2..606
FT                   /note="Ribonucleoprotein PTB-binding 1"
FT                   /id="PRO_0000081487"
FT   DOMAIN          59..130
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          132..210
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          221..299
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          307..395
FT                   /note="Interaction with PTBP1"
FT                   /evidence="ECO:0000250"
FT   MOTIF           45..60
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        406..468
FT                   /note="Pro-rich"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         463
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         474
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CW46"
FT   VAR_SEQ         74..75
FT                   /note="EV -> PS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11853319"
FT                   /id="VSP_040968"
FT   VAR_SEQ         76..606
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11853319"
FT                   /id="VSP_040969"
FT   VAR_SEQ         477
FT                   /note="R -> RGLQKDSGPLPTPPGVSLLGEPPKDYRIPLNPYLNLHSLLPASNLAG
FT                   KEARGWGGAGRSRRPAEGPLTNPPAPGGGSSSSKAFQLKSRLLSPLSSARLPPEPGLSD
FT                   SYSFDYPSDMGPRRLFSHPREPALGPHGPSRHKMSPPPSGFGERSSGGSGG (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017035"
FT   VAR_SEQ         536..606
FT                   /note="VRAGGGDMQGWEAPAPQRPLTRPALPSVSRPHWAARNAALPTCCPRPSPAQK
FT                   AAMWASTPRASAATTRTPT -> TPLGGQKRSFAHLLPSPEPSPEGSYVGQHSQGLGGH
FT                   YADSYLKRKRIF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017036"
FT   HELIX           41..56
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          60..64
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           72..78
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   TURN            79..81
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          84..90
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   TURN            91..94
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          95..102
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           103..113
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          124..127
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          133..138
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           145..152
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           153..155
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          158..165
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   TURN            167..169
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          172..182
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           183..193
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          204..207
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           210..212
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   TURN            215..218
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          221..226
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           235..241
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          244..246
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          249..255
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          261..268
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           272..282
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          293..296
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   STRAND          299..301
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   HELIX           303..313
FT                   /evidence="ECO:0007744|PDB:3SMZ"
FT   MOD_RES         Q8IY67-2:488
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         Q8IY67-2:567
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
SQ   SEQUENCE   606 AA;  63877 MW;  09FA9935A6281B42 CRC64;
     MAADVSVTHR PPLSPKSGAE VEAGDAAERR APEEELPPLD PEEIRKRLEH TERQFRNRRK
     ILIRGLPGDV TNQEVHDLLS DYELKYCFVD KYKGTAFVTL LNGEQAEAAI NAFHQSRLRE
     RELSVQLQPT DALLCVANLP PSLTQQQFEE LVRPFGSLER CFLVYSERTG QSKGYGFAEY
     MKKDSAARAK SDLLGKPLGP RTLYVHWTDA GQLTPALLHS RCLCVDRLPP GFNDVDALCR
     ALSAVHSPTF CQLACGQDGQ LKGFAVLEYE TAEMAEEAQQ QADGLSLGGS HLRVSFCAPG
     PPGRSMLAAL IAAQATALNR GKGLLPEPNI LQLLNNLGPS ASLQLLLNPL LHGSAGGKQG
     LLGAPPAMPL LNGPALSTAL LQLALQTQGQ KKPGILGDSP LGALQPGAQP ANPLLGELPA
     GGGLPPELPP RRGKPPPLLP SVLGPAGGDR EALGLGPPAA QLTPPPAPVG LRGSGLRGPL
     SHFYSGSPTS YFTSGLQAGL KQSHLSKAIG SSPLGSGEGL LGLSPGPNGH SHLLKVRAGG
     GDMQGWEAPA PQRPLTRPAL PSVSRPHWAA RNAALPTCCP RPSPAQKAAM WASTPRASAA
     TTRTPT
//
